Pulmocef CV 250mg/62.50mg Tablet
Marketer
Micro Labs Ltd
Salt Composition
Cefuroxime (250mg) + Clavulanic Acid (62.50mg)
Overview Pulmocef CV 250mg/62.50mg Tablet
Combiflox 250mg/62.50mg tablets combat various bacterial infections by inhibiting microbial proliferation. This prescription medication, taken as directed, can be administered with or without food, but consistent timing maximizes effectiveness. Exceeding the prescribed dosage can be detrimental. Missed doses should be taken promptly upon recollection. Complete the entire course of treatment, even with symptom improvement, as premature cessation may reduce efficacy. Typical mild side effects include nausea, vomiting, diarrhea, and indigestion; worsening side effects warrant immediate medical attention. Seek immediate medical help for allergic reactions (rashes, itching, swelling, difficulty breathing). Inform your physician of all current medications, especially if pregnant or breastfeeding, before commencing treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While usually non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to faster recovery. Your doctor may order tests to monitor the medication's effects.
Uses of Pulmocef CV 250mg/62.50mg Tablet
Combating Bacterial Infections
Major Benefits of Pulmocef CV 250mg/62.50mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. The Pulmocef CV 250mg/62.50mg Tablet should be swallowed whole; do not crush, chew, or break it. While it can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Pulmocef CV 250mg/62.50mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Increased liver enzymes
- Allergic reaction
How to use Pulmocef CV 250mg/62.50mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Pulmocef CV 250mg/62.50mg Tablets can be consumed with or without food, although consistent timing is recommended.
How Pulmocef CV 250mg/62.50mg Tablet works:
Pulmocef CV 250mg/62.50mg tablets contain Cefuroxime, an antibiotic, and Clavulanic Acid, a beta-lactamase inhibitor. Cefuroxime combats bacterial infection by disrupting the formation of their protective cell walls. Clavulanic Acid counteracts bacterial enzymes that would otherwise deactivate Cefuroxime, thereby broadening the antibiotic's effectiveness and overcoming bacterial resistance.
SAFETY ADVICE
AlcoholSAFE
Ingesting alcohol alongside Pulmocef CV 250mg/62.50mg tablets poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The use of Pulmocef CV 250mg/62.50mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Lactation and the use of Pulmocef CV 250mg/62.50mg tablets are compatible. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingNOT RELEVANT
Irrelevant; Pulmocef CV 250mg/62.50mg tablets are prescribed exclusively for inpatients.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Pulmocef CV 250mg/62.50mg tablets to individuals with renal impairment. Seek medical advice from your physician.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Pulmocef CV 250mg/62.50mg tablets to individuals with hepatic impairment. Seek medical advice.
What if you forget to take Pulmocef CV 250mg/62.50mg Tablet :
Should you forget a dose of Pulmocef CV 250mg/62.50mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Pulmocef CV 250mg/62.50mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobials |



